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Patients with atrial fibrillation (AF) have an increased risk of ischemic stroke, transient 
ischemic attack (TIA), and systemic embolism compared to patients without AF (1). In patients 
with AF, several risk factors are well documented an included in risk scores used for risk 
stratification. These include advancing age, diabetes mellitus, hypertension, congestive heart 
disease, peripheral artery disease, and previous stroke/TIA, among others. Coronary artery 
disease (CAD) and ischemic stroke share several common risk factors, but whether CAD is an 
independent risk factor for ischemic stroke among patients with AF has not yet been examined. 
The aim of this study was to investigate whether th presence of CAD provided independent 
prognostic information of the risk of future ischemic stroke and thromboembolism in patients 
with AF.  
The association between CAD and ischemic stroke ris was examined in a large 
prospectively collected dataset of consecutive patients with AF who underwent coronary 
angiography in Western Denmark between July 1, 2004 and December 1, 2012. All patients’ 
angiographic findings are registered in the Western De mark Heart Registry (2) by use of each 
patient’s unique 10-digit personal identifier, whic is a personal number assigned to each Danish 
resident upon birth or after immigration. This personal identifier is used throughout every 
regional and national registry, where it ensures accurate cross linkage of healthcare information 
and minimizes loss to follow-up. Patient data from the Western Denmark Heart Registry 
concerning the patients’ angiographic findings were cross linked with information from the 
Danish National Patient Registry,(3) which records all hospital-based inpatient and outpatient 
diagnoses, and the Danish National Database of Reimbursed Prescriptions (3), which contains 
data on all reimbursed prescriptions at Danish pharmacies. 
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The total study cohort was divided into two groups; atients with CAD and patients 
without CAD. CAD was defined as obstructive (≥50%) coronary stenosis in ≥1 coronary vessel, 
or non-obstructive coronary stenoses in ≥2 coronary vessels. The primary endpoint was a 
composite of ischemic stroke, TIA, and systemic embolism obtained from the Danish National 
Patient Registry. Follow-up began 30 days after the ind x coronary angiography, and continued 
until endpoint event, death, emigration, or end of follow-up, whichever came first. The risk of 
ischemic stroke, TIA, and systemic embolism was estimated separately for both groups, and 
incidence rate ratios (IRR) were calculated with modified Poisson regression using patients 
without CAD as reference. We adjusted for age, gender, diabetes mellitus, hypertension, 
congestive heart disease, previous stroke/TIA, vascul r disease (previous myocardial infarction 
and/or peripheral artery disease/aortic plaque), antipl telet treatment, oral anticoagulant 
treatment, and statin treatment. 
Out of 96,430 patients undergoing coronary angiography between 2004-2012, a total of 
12,690 patients had a diagnosis of AF, were 18 years or above and had a follow-up time of >30 
days. Among these patients 7,533 patients (59.4%) had CAD and 5,157 patients (40.6%) had no 
CAD. Maximal follow-up was 8.4 years, and median follow-up was 3 years (IQR 1.3-5.2). 
Baseline characteristics are shown in Table 1. The rate of ischemic stroke/TIA/thromboembolism 
was 2.62 (95% confidence interval (CI) 2.42-2.84) per 100 person-years for patients with CAD 
and 1.61 (95% CI 1.43-1.81) per 100 person-years for patients without CAD. Crude IRR was 
1.62 (95% CI 1.41-1.87). The impact of presence of CAD remained significant after adjustment 
and suggested a 29% increased risk of ischemic stroke/TIA/thromboembolism (adjusted IRR 
1.29, 95% CI 1.08-1.53). 
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Our study suggests that CAD is an independent risk factor for ischemic stroke among 
patients with AF. The association between CAD and ischemic stroke has also been indicated in a 
previous study analyzing our entire cohort, i.e. prima ily including patients without AF.(3) 
Patients with AF, however, have a greater risk of ischemic stroke than patients without AF. 
Moreover, prophylactic oral anticoagulant therapy is well-documented in patients with AF but 
not in non-AF patients. There are several risk scores recommended for risk stratification of AF 
patients into those with a low risk of thromboembolic events (no indication for oral 
anticoagulation) and those with a high risk (indication for oral anticoagulation) of 
thromboembolic events including ischemic stroke. According to the current study, CAD is an 
independent risk factor for thromboembolic events icluding ischemic stroke in AF patients. 
Consequently, we suggest that CAD should be considered as a potential additional risk factor in 
the risk scores used for stratification of AF patients.  
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Table 1. Baseline characteristics of 12,690 patients with atrial fibrillation undergoing 
coronary angiography 
  
No CAD*  Any CAD Total 
  (n=5,157) (n=7,533) (n=12,690) 
    n (%) n (%) n (%) 
Age   
 
<65 years 2,050 (39.8) 1,478 (19.6) 3,528 (27.8) 
 
65-74 years 1,764 (34.2) 2,801 (37.2) 4,565 (36.0) 
 ≥75 years 1,343 (26.0) 3,254 (43.2) 4,597 (36.2) 
Gender 
   
 
Male 3,081 (59.7) 5,363 (71.2) 8,444 (66.5) 
 
Female 2,076 (40.3) 2,170 (28.8) 4,246 (33.5) 
Smoking status  
 
Never/former 3,632 (70.4) 5,105 (67.8) 8,737 (68.8) 
 
Active 835 (16.2) 1,501 (19.9) 2,336 (18.4) 
 
Missing 690 (13.4) 927 (12.3) 1,617 (12.7) 
Comorbidities 
 
 
Diabetes mellitus 735 (14.3) 1,664 (22.1) 2,399 (18.9) 
 
Hypertension 3,033 (58.8) 5,420 (72.0) 8,453 (66.6) 
 
Congestive heart failure 1,933 (37.5) 2,991 (39.7) 4,924 (38.8) 
 
Stroke/TIA† 564 (10.9) 1,116 (14.8) 1,680 (13.2) 
 
Vascular disease‡ 733 (15.0) 3,752 (49.8) 4,525 (35.7) 
 
PAD§/aortic plaque 282 (5.5) 1,087 (14.4) 1,369 (10.8) 
 
Previous myocardial infarction 536 (10.4) 3,171 (42.1) 3,707 (29.2) 
Medical treatment  
 
Vitamin K antagonists 3,390 (65.7) 4,125 (54.8) 7,515 (59.2) 
 
NOAC// 97 (1.9) 119 (1.6) 216 (1.7) 
 
Aspirin 2,608 (50.6) 5,919 (78.6) 8,527 (67.2) 
 
Statin 2,226 (43.2) 5,915 (78.5) 8,141 (64.2) 
 
* CAD: Coronary artery disease 
† TIA: Transient ischemic attack 
‡ Vascular disease: Presence of previous myocardial infarction and/or peripheral artery 
disease/aortic plaque. 
§ PAD: Peripheral artery disease 
// NOAC: Non-vitamin K antagonist anticoagulant treatment 
 
